EA201990568A1 - REGULATION OF EXPRESSION OF GENES USING CONSTRUCTED NUCLEASES - Google Patents

REGULATION OF EXPRESSION OF GENES USING CONSTRUCTED NUCLEASES

Info

Publication number
EA201990568A1
EA201990568A1 EA201990568A EA201990568A EA201990568A1 EA 201990568 A1 EA201990568 A1 EA 201990568A1 EA 201990568 A EA201990568 A EA 201990568A EA 201990568 A EA201990568 A EA 201990568A EA 201990568 A1 EA201990568 A1 EA 201990568A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nucleases
genes
regulation
expression
constructed
Prior art date
Application number
EA201990568A
Other languages
Russian (ru)
Inventor
Джеффри К. Миллер
Эдвард Дж. Ребар
Original Assignee
Сангамо Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сангамо Терапьютикс, Инк. filed Critical Сангамо Терапьютикс, Инк.
Priority claimed from PCT/US2017/048397 external-priority patent/WO2018039440A1/en
Publication of EA201990568A1 publication Critical patent/EA201990568A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Данное изобретение относится к области геномной инженерии, в частности к направленной модификации генома гемопоэтической клетки.This invention relates to the field of genomic engineering, in particular to directed modification of the genome of a hematopoietic cell.

EA201990568A 2017-08-15 2017-08-24 REGULATION OF EXPRESSION OF GENES USING CONSTRUCTED NUCLEASES EA201990568A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762545778P 2017-08-15 2017-08-15
PCT/US2017/048397 WO2018039440A1 (en) 2016-08-24 2017-08-24 Regulation of gene expression using engineered nucleases

Publications (1)

Publication Number Publication Date
EA201990568A1 true EA201990568A1 (en) 2019-07-31

Family

ID=67399630

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990568A EA201990568A1 (en) 2017-08-15 2017-08-24 REGULATION OF EXPRESSION OF GENES USING CONSTRUCTED NUCLEASES

Country Status (1)

Country Link
EA (1) EA201990568A1 (en)

Similar Documents

Publication Publication Date Title
PH12019500281A1 (en) Regulation of gene expression using engineered nucleases
MX2021005226A (en) Nuclease-mediated regulation of gene expression.
CY1121630T1 (en) NUCLEASE-MEDIATED REGULATION OF GLOBAL GENE EXPRESSION
EA201890565A1 (en) COMPOSITIONS AND METHODS OF IMPROVING SPECIFICITY IN GENOMIC ENGINEERING WITH THE USE OF RNA-DIRECTED ENDONUCLEAS
DK3684930T3 (en) Modification of the specificity of non-coding plant RNA molecules for inactivation of gene expression
EA201891532A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF HEMOGLOBINOPATHY
EA201690403A1 (en) COMPOSITIONS AND METHODS FOR RNA MODULATION
MX2017010746A (en) Composition and methods for regulated expression of a guide rna/cas endonuclease complex.
UA120923C2 (en) Further improved aav vectors produced in insect cells
MX2016005876A (en) Optimal maize loci.
DOP2022000085A (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE
EA039598B9 (en) Compound targeting il-23a and tnf-alpha and uses thereof
EA201890360A1 (en) A compound targeting IL-23A and the activation factor of β-lymphocytes (BAFF), and its application
DK3224364T3 (en) CAUSATIVE GENES WHICH PROVIDE ACID ACID TOLERANCE YESTERDAY
MX2022000516A (en) Methods relating to pluripotent cells.
NI201600114S (en) INDUSTRIAL MODEL OF PEN
EA201990568A1 (en) REGULATION OF EXPRESSION OF GENES USING CONSTRUCTED NUCLEASES
EA201591444A1 (en) MUTED ALLENOXIDE SYNTHASE 2 GENES (AOS2)
EA201992503A1 (en) Melon Plants Resistant to ToLCNDV Virus
MA44924B1 (en) Regulation of gene expression using modified nucleases
EA202090046A1 (en) DNA FIRMED AIMS
UA124893U (en) METHOD OF ASSESSMENT OF GENE EXPRESSION LEVELS IN CRYCONSERVED HEMOPOETIC FETAL LIVER CELLS